United KingdomHealthcare and life sciences2022 – ongoingNHS Lanarkshire
Infix operating-theatre scheduling trial
Infix reported 27% higher theatre utilisation in an NHS Lanarkshire trial
Problem
Surgical backlogs put pressure on hospitals to make better use of existing operating-theatre capacity.
Approach
NHS Lanarkshire had completed a clinical trial of Infix's theatre-scheduling software by November 2022. The cloud-based system supported theatre scheduling using machine learning. The trial's exact start date was not disclosed.
Results
Takeaway
Infix reported higher theatre utilisation in a completed NHS Lanarkshire trial. It did not disclose the baseline, sample size or comparison method.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and MLOptimization
- Adoption
- Vendor solution
- Evidence
- Vendor case study
Sources
Source summaries
The Scotsman reported that a completed NHS Lanarkshire trial preceded Infix's NHS Lothian contract. It attributed a 27% increase in theatre utilisation to the firm.
The parliamentary briefing classified Infix as machine-learning scheduling software. It described its use to improve operating-theatre scheduling in NHS Lothian.
Full details are in the original sources.